Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

Recent Healthcare Stocks Articles

7 Value Stocks to Buy and Hold for a Decade of Dominance

Discover the enduring value of seven key value stocks to buy and hold in diverse sectors, presenting unparalleled opportunities.

3 Top Small-Cap Growth Opportunities in the AI Era

Small AI firms are benefiting from the pervasive, positive publicity about AI. Here are three small-cap growth stocks to buy.

3 Cheap Healthcare Stocks to Buy Now: May 2024

Healthcare is cheaper than the market and has secular growth tailwinds, meaning these cheap healthcare stocks have upside.

Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 

With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead.

Storm Shelter: 7 Safe Haven Stocks to Batten Down the Hatches

With the market potentially entering a period of consolidation, investors may want to consider safe haven stocks to buy. No, it’s not the most exciting…

From Hype to Bust: The Downfall of Teladoc, Bark and Nike Stocks

These stocks to sell may not be major tech players or overvalued meme stocks, but they're still stinkers and not worth a second look.

Cannabis Stocks CGC, TLRY, ACB, MSOS, CRON Pop as Justice Department Moves on Rescheduling

Cannabis stocks are among the big movers investors are watching closely as a key piece of legislation is pushed forward for this sector.

Underpriced Stocks: 3 Hidden Gems Worth Snagging Now

Investors seeking growth potential in underpriced stocks to buy may uncover hidden growth in these standouts.

Why Is Lucy Scientific Discovery (LSDI) Stock Up 227% Today?

Lucy Scientific Discovery stock is up on Thursday with heavy trading of LSDI shares despite a lack of news that would cause a rally.

The Dividend Investor’s Playbook: 3 Stocks for Consistent Cash Flow in 2024

Amid economic shifts, pinpoint dividend stocks to buy: Disney's recovery, Walmart's expansion, and Eli Lilly's medical innovations stand out.

Wall Street Favorites: 3 Cannabis Stocks with Strong Buy Ratings for May 2024 

Cannabis stocks to buy could see higher highs on several key catalysts. In fact, here are three stocks you may want to buy today.

Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade

The FTC is putting these three drug stocks at risk by trying to strip their therapies of protection from generics.

Wall Street Favorites: 3 Retirement Stocks With Strong Buy Ratings for May 2024

What could be better than well-established retirement stocks to buy that you can trust? How about adding to that confidence level with the backing of…

Why Is Virpax Pharmaceuticals (VRPX) Stock Down 61% Today?

Virpax Pharmaceuticals stock is falling on Wednesday as VRPX investors continue to sell shares following its latest earnings report.

Why Is Sintx Technologies (SINT) Stock Up 113% Today?

Sintx Technologies stock is up on Wednesday alongside heavy SINT trading as it appears to be joining the Roaring Kitty meme rally.

3 High-Potential Stocks to Buy at Rock-Bottom Prices

Discover cheap stocks with high potential and growth prospects in electronic manufacturing services and healthcare technology.

3 Short-Squeeze Stocks Ready to Soar on Roaring Kitty Rally

The Roaring Kitty rally could give rise to a new group of winners. Here are the best short squeeze stocks for investors to watch.

3 Cheap Biotech Stocks to Buy Now: May 2024

Many of these cheap biotech stocks are on their way to achieving FDA approval for their drugs to enter the market.

Why Is Augmedix (AUGX) Stock Down 41% Today?

Augmedix stock is down on Tuesday as investors in AUGX shares are unimpressed with the company's updated revenue outlook for 2024!